NASDAQInformation TechnologySemiconductorsSnapshot 2026-07-31
Reading LASR? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Semiconductors is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue growth is accelerating — up about 41% over the past year.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 37%, softest on share dilution.
View QualityManagement screens weak on capital allocation, earnings delivery, the balance sheet.
View ManagementExpectations look high — the market is pricing in about 31% growth a year, above the roughly 14% analysts expect, leaving little room for error.
View ValuationThis stock is volatile — it swings about 4% on a typical day and fell roughly 31% in its worst 12-month stretch.
View RiskLASR's growth depends on its ability to improve financial performance and guidance. Revenue has been steady, but it remains unprofitable. The stock trades at 13.6 times price-to-sales, above the 8.7 times peer median. The market expects more growth than the company has shown, which looks full. If LASR cuts guidance, it could face a significant drop. Peer multiples imply a price about 25% below where it trades. This read is provisional.
Trailing returns as of 2026-07-31. LASR is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 9 analysts currently covering LASR (as of Jul 2026).
Based on 6 Wall Street analysts offering 12-month price targets for LASR in the last 4 months.
A consensus fair price across 4 valuation methods, at three horizons. As of 2026-08-01. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Semiconductors — fair value, gap to price, and forward P/E.
CEO stock sale may signal lack of confidence.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-31. EPS is implied from price ÷ P/E. Not investment advice.
Current $68.80
The last 12 months of price, then the range of analyst 12-month targets from today’s $68.80.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
CEO stock sale raises concerns among investors.
Large stock sale by CEO may indicate issues.
Expansion in defense operations supports revenue growth.
Increased price target reflects positive outlook.
Strong Q1 results and guidance support revenue goals.
